Influence of OATP1B1 Function on the Disposition of Sorafenib-β-D-Glucuronide-Reference-Cited by-同舟云学术

Influence of OATP1B1 Function on the Disposition of Sorafenib-β-D-Glucuronide

Published:2017-03-31 Issue:4 Volume:10 Page:271-279
ISSN:1752-8054
Container-title:Clinical and Translational Science
language:en
Short-container-title:Clinical And Translational Science

Author:

Bins S¹,van Doorn L¹,Phelps MA²,Gibson AA²,Hu S²,Li L³,Vasilyeva A³,Du G³,Hamberg P⁴,Eskens FALM¹,de Bruijn P¹,Sparreboom A¹²,Mathijssen RHJ¹,Baker SD²

Affiliation:

1. Department of Medical Oncology; Erasmus MC Cancer Institute; Wytemaweg Rotterdam The Netherlands

2. Division of Pharmaceutics and Pharmaceutical Chemistry; College of Pharmacy; Ohio State University; Columbus Ohio USA

3. Department of Pharmaceutical Sciences; St. Jude Children's Research Hospital; Memphis Tennessee USA

4. Department of Internal Medicine; St. Franciscus Gasthuis; Rotterdam The Netherlands

Funder

ALSAC

National Institutes of Health

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/cts.12458/fullpdf

Reference42 articles.

1. Sorafenib in advanced clear-cell renal-cell carcinoma;Escudier;N. Engl. J. Med.,2007

2. Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial;Brose;Lancet,2014

3. Sorafenib in advanced hepatocellular carcinoma;Llovet;N. Engl. J. Med.,2008

4. Safety, pharmacokinetics, and preliminary antitumor activity of sorafenib: a review of four phase I trials in patients with advanced refractory solid tumors;Strumberg;Oncologist,2007

5. Effects of Sorafenib dose on acquired reversible resistance and toxicity in hepatocellular carcinoma;Kuczynski;Cancer Res.,2015

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug-drug interactions that alter the exposure of glucuronidated drugs: Scope, UDP-glucuronosyltransferase (UGT) enzyme selectivity, mechanisms (inhibition and induction), and clinical significance;Pharmacology & Therapeutics;2023-08

2. Targeting a xenobiotic transporter to ameliorate vincristine-induced sensory neuropathy;JCI Insight;2023-07-24

3. Enhanced imatinib uptake through influx transporters and its quantification based on LC-MS/MS in human leukemic cells;2023-05-23

4. Drug-drug interactions associated with FLT3 inhibitors for acute myeloblastic leukemia: current landscape;Expert Review of Clinical Pharmacology;2023-02-01

5. SLCO1B1 Pharmacogenetics in Pediatrics;Advances in Molecular Pathology;2022-11